Status:
UNKNOWN
Contrast Induced Nephropathy Among Vascular Patients Undergoing Lower Limb Angioplasty
Lead Sponsor:
Singapore General Hospital
Conditions:
Contrast-induced Nephropathy
Eligibility:
All Genders
21+ years
Brief Summary
Contrast induced nephropathy (CIN) is an iatrogenic renal injury following intravascular administration of radio-opaque contrast media (CM) in susceptible individuals. As the third leading cause of ho...
Detailed Description
We propose a retrospective single-center cohort study conducted in Singapore general hospital. Data would be extracted in patients who have undergone peripheral endovascular angioplasty from 01/01/201...
Eligibility Criteria
Inclusion
- All patients undergoing peripheral endovascular angioplasty during the study period, at Singapore General Hospital
Exclusion
- Patients \< 21 years of age
Key Trial Info
Start Date :
July 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04879186
Start Date
July 1 2015
End Date
July 1 2021
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169608